Intellectual Property
Patents
Phyla products and technologies are protected by patents in the United States and other jurisdictions.
U.S. Patents
Acne
Our acne technology is protected by the following U.S. patents.
U.S. Patent No.
11,903,984
Issued Feb. 20, 2024
Title
Compositions Comprising Propionibacterium acnes Bacteriophages for Treating Acne
U.S. Patent No.
12,576,024
Issued Mar. 17, 2026
Title
Compositions Comprising Bacteriophages for Treating Acne
U.S. Patents
Eczema
Our eczema technology is protected by the following U.S. patent.
U.S. Patent No.
12,605,416
Issued Apr. 21, 2026
Title
Compositions and Methods for the Treatment of Skin Diseases and Conditions Including Eczema
Additional Patents
Phyla also has issued and pending patents in other jurisdictions, including Japan, Australia, Canada, China, Europe, and South Korea.
This page is intended to serve as notice under 35 U.S.C. § 287(a). Additional patents and patent applications may be issued or pending in the United States and other jurisdictions.
Last updated September 2026
For more information about our intellectual property, please contact us.